Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition
Sun, Steven, Pithavala, Yazdi K., Martini, Jean‐François, Chen, Joseph
Published in Journal of clinical pharmacology (01.09.2022)
Published in Journal of clinical pharmacology (01.09.2022)
Get full text
Journal Article
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
Motzer, Robert J., Martini, Jean-François, Mu, Xinmeng J., Staehler, Michael, George, Daniel J., Valota, Olga, Lin, Xun, Pandha, Hardev S., Ching, Keith A., Ravaud, Alain
Published in Nature communications (10.10.2022)
Published in Nature communications (10.10.2022)
Get full text
Journal Article
Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147), a Pan‐Class I PI3K Inhibitor, in Combination With Erlotinib in Patients With Solid Tumors
Soria, Jean‐Charles, LoRusso, Patricia, Bahleda, Ratislav, Lager, Joanne, Liu, Li, Jiang, Jason, Martini, Jean‐François, Macé, Sandrine, Burris, Howard
Published in The oncologist (Dayton, Ohio) (01.03.2015)
Published in The oncologist (Dayton, Ohio) (01.03.2015)
Get full text
Journal Article
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M, Felip, Enriqueta, Martini, Jean-François
Published in Journal of clinical oncology (01.06.2019)
Published in Journal of clinical oncology (01.06.2019)
Get full text
Journal Article
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
Ravaud, Alain, Motzer, Robert J, Pandha, Hardev S, George, Daniel J, Pantuck, Allan J, Patel, Anup, Chang, Yen-Hwa, Escudier, Bernard, Donskov, Frede, Magheli, Ahmed, Carteni, Giacomo, Laguerre, Brigitte, Tomczak, Piotr, Breza, Jan, Gerletti, Paola, Lechuga, Mariajose, Lin, Xun, Martini, Jean-Francois, Ramaswamy, Krishnan, Casey, Michelle, Staehler, Michael, Patard, Jean-Jacques
Published in The New England journal of medicine (08.12.2016)
Published in The New England journal of medicine (08.12.2016)
Get full text
Journal Article
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Shaw, Alice T, Felip, Enriqueta, Bauer, Todd M, Besse, Benjamin, Navarro, Alejandro, Postel-Vinay, Sophie, Gainor, Justin F, Johnson, Melissa, Dietrich, Jorg, James, Leonard P, Clancy, Jill S, Chen, Joseph, Martini, Jean-François, Abbattista, Antonello, Solomon, Benjamin J
Published in The lancet oncology (01.12.2017)
Published in The lancet oncology (01.12.2017)
Get full text
Journal Article
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
Shaw, Alice T, Solomon, Benjamin J, Chiari, Rita, Riely, Gregory J, Besse, Benjamin, Soo, Ross A, Kao, Steven, Lin, Chia-Chi, Bauer, Todd M, Clancy, Jill S, Thurm, Holger, Martini, Jean-Francois, Peltz, Gerson, Abbattista, Antonello, Li, Sherry, Ou, Sai-Hong Ignatius
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Rodon, Jordi, Soria, Jean-Charles, Berger, Raanan, Miller, Wilson H., Rubin, Eitan, Kugel, Aleksandra, Tsimberidou, Apostolia, Saintigny, Pierre, Ackerstein, Aliza, Braña, Irene, Loriot, Yohann, Afshar, Mohammad, Miller, Vincent, Wunder, Fanny, Bresson, Catherine, Martini, Jean-François, Raynaud, Jacques, Mendelsohn, John, Batist, Gerald, Onn, Amir, Tabernero, Josep, Schilsky, Richard L., Lazar, Vladimir, Lee, J. Jack, Kurzrock, Razelle
Published in Nature Medicine (01.05.2019)
Published in Nature Medicine (01.05.2019)
Get full text
Journal Article
Magazine Article
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Felip, Enriqueta, Soo, Ross A, Camidge, D Ross, Chiari, Rita, Bearz, Alessandra, Lin, Chia-Chi, Gadgeel, Shirish M, Riely, Gregory J, Tan, Eng Huat, Seto, Takashi, James, Leonard P, Clancy, Jill S, Abbattista, Antonello, Martini, Jean-François, Chen, Joseph, Peltz, Gerson, Thurm, Holger, Ou, Sai-Hong Ignatius, Shaw, Alice T
Published in The lancet oncology (01.12.2018)
Published in The lancet oncology (01.12.2018)
Get full text
Journal Article
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial
Soo, Ross A., Huat Tan, Eng, Hayashi, Hidetoshi, Seto, Takashi, Lin, Chia-Chi, Ou, Sai-Hong Ignatius, Kim, Dong-Wan, Liu, Geoffrey, Abbattista, Antonello, Martini, Jean-François, Hooi Wong, Chew, Toffalorio, Francesca, Solomon, Benjamin J.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2022)
Get full text
Journal Article
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Rini, Brian, Prof, Goddard, Audrey, PhD, Knezevic, Dejan, PhD, Maddala, Tara, PhD, Zhou, Ming, MD, Aydin, Hakan, MD, Campbell, Steven, MD, Elson, Paul, PhD, Koscielny, Serge, PhD, Lopatin, Margarita, MS, Svedman, Christer, MD, Martini, Jean-Francois, PhD, Williams, J Andrew, PhD, Verkarre, Virginie, MD, Radulescu, Camelia, MD, Neuzillet, Yann, MD, Hemmerlé, Isabelle, BS, Timsit, Marc Olivier, MD, Tsiatis, Athanasios C, MD, Bonham, Michael, MD, Lebret, Thierry, Prof, Mejean, Arnaud, Prof, Escudier, Bernard, MD
Published in The lancet oncology (01.06.2015)
Published in The lancet oncology (01.06.2015)
Get full text
Journal Article
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial
Adkins, Douglas R., Lin, Jin-Ching, Sacco, Assuntina, Ley, Jessica, Oppelt, Peter, Vanchenko, Vyacheslay, Komashko, Nataliia, Yen, Chia-Jui, Wise-Draper, Trisha, Lopez-Picazo Gonzalez, Jose, Radulovic, Sinisa, Shen, Qi, Thurm, Holger, Martini, Jean-François, Hoffman, Justin, Huang, Xin, Melichar, Bohuslav, Tahara, Makoto
Published in Oral oncology (01.04.2021)
Published in Oral oncology (01.04.2021)
Get full text
Journal Article
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
Bearz, Alessandra, Martini, Jean-François, Jassem, Jacek, Kim, Sang-We, Chang, Gee-Chen, Shaw, Alice T., Shepard, Deborah A., Dall’O’, Elisa, Polli, Anna, Thurm, Holger, Zalcman, Gerard, Garcia Campelo, Maria Rosario, Penkov, Konstantin, Hayashi, Hidetoshi, Solomon, Benjamin J.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Martini, Jean-François, Plimack, Elizabeth R, Choueiri, Toni K, McDermott, David F, Puzanov, Igor, Fishman, Mayer N, Cho, Daniel C, Vaishampayan, Ulka, Rosbrook, Bradley, Fernandez, Kathrine C, Tarazi, Jamal C, George, Saby, Atkins, Michael B
Published in Clinical cancer research (01.11.2020)
Published in Clinical cancer research (01.11.2020)
Get full text
Journal Article
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
Patel, Anup, Ravaud, Alain, Motzer, Robert J, Pantuck, Allan J, Staehler, Michael, Escudier, Bernard, Martini, Jean-François, Lechuga, Mariajose, Lin, Xun, George, Daniel J
Published in Clinical cancer research (15.09.2020)
Published in Clinical cancer research (15.09.2020)
Get full text
Journal Article
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
George, Daniel J, Martini, Jean-François, Staehler, Michael, Motzer, Robert J, Magheli, Ahmed, Escudier, Bernard, Gerletti, Paola, Li, Sherry, Casey, Michelle, Laguerre, Brigitte, Pandha, Hardev S, Pantuck, Allan J, Patel, Anup, Lechuga, Maria J, Ravaud, Alain
Published in Clinical cancer research (01.04.2018)
Published in Clinical cancer research (01.04.2018)
Get full text
Journal Article
Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues
Touraine, Philippe, Martini, Jean-François, Zafrani, Brigitte, Durand, Jean-Claude, Labaille, Françoise, Malet, Catherine, Nicolas, André, Trivin, Christine, Postel-Vinay, Marie-Catherine, Kuttenn, Frédérique, Kelly, Paul A
Published in The journal of clinical endocrinology and metabolism (01.02.1998)
Published in The journal of clinical endocrinology and metabolism (01.02.1998)
Get full text
Journal Article
Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC
Soo, Ross A., Martini, Jean-François, van der Wekken, Anthonie J., Teraoka, Shunsuke, Ferrara, Roberto, Shaw, Alice T., Shepard, Deborah, Calella, Anna Maria, Polli, Anna, Toffalorio, Francesca, Tomasini, Pascale, Chiu, Chao-Hua, Kowalski, Dariusz M., Kim, Hye Ryun, Solomon, Benjamin J.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
16K Human Prolactin Inhibits Vascular Endothelial Growth Factor-Induced Activation of Ras in Capillary Endothelial Cells
D’Angelo, Gisela, Martini, Jean-François, Iiri, Taroh, Fantl, Wendy J, Martial, Joseph, Weiner, Richard I
Published in Molecular endocrinology (Baltimore, Md.) (01.05.1999)
Published in Molecular endocrinology (Baltimore, Md.) (01.05.1999)
Get full text
Journal Article
Web Resource
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non–Small Cell Lung Cancer: Results of a Phase I Study
Jänne, Pasi A., Shaw, Alice T., Camidge, D. Ross, Giaccone, Giuseppe, Shreeve, S. Martin, Tang, Yiyun, Goldberg, Zelanna, Martini, Jean-François, Xu, Huiping, James, Leonard P., Solomon, Benjamin J.
Published in Journal of thoracic oncology (01.05.2016)
Published in Journal of thoracic oncology (01.05.2016)
Get full text
Journal Article